Trabeculectomy is a surgical procedure that creates a new drainage pathway in the eye to lower intraocular pressure (IOP) in people with glaucoma. It remains the most widely performed glaucoma surgery worldwide, typically reserved for cases where eye drops or laser treatments haven’t kept pressure under control. The surgery works by making a small opening in the white of the eye, allowing fluid to drain into a small pocket under the surface tissue, where the body gradually absorbs it.
How the Surgery Works
Your eye constantly produces a clear fluid called aqueous humor, which nourishes internal structures and maintains the eye’s shape. In a healthy eye, this fluid drains through a mesh-like tissue near the iris. In glaucoma, that drainage system doesn’t work properly, so fluid builds up and pressure rises, eventually damaging the optic nerve.
During trabeculectomy, the surgeon creates a partial-thickness flap in the sclera (the white outer wall of the eye), then cuts a small hole underneath it that connects to the interior of the eye. This hole allows aqueous humor to flow out through a new channel. The flap acts like a valve, controlling how fast fluid escapes. Stitches hold the flap in place and can be adjusted after surgery to fine-tune the pressure. Over the following months, the body forms a permanent drainage channel extending from the interior of the eye through the sclera to the tissue covering it. Fluid collects in a small, fluid-filled bump called a filtering bleb, usually hidden under the upper eyelid, where it’s absorbed into surrounding blood vessels.
Who Needs a Trabeculectomy
Trabeculectomy is not a first-line treatment. It’s recommended when eye pressure remains dangerously high despite maximum tolerated medication, or when patients can’t use their drops consistently due to side effects, allergies, or difficulty with the regimen. Significant pressure swings between visits (differences greater than 10 mmHg) can also prompt surgery, since unstable pressure accelerates nerve damage even when average readings look acceptable. The decision also weighs how much vision has already been lost, the health of the other eye, and the patient’s expected lifespan, since younger patients face more years of potential damage.
Trabeculectomy vs. Newer Procedures
Minimally invasive glaucoma surgeries (MIGS) have expanded surgical options considerably, and many patients wonder how they compare. The short answer: trabeculectomy lowers pressure more aggressively, while MIGS procedures carry fewer risks and a lighter recovery. A systematic review and meta-analysis found that trabeculectomy achieves greater IOP reduction overall, but MIGS offers a more favorable safety profile and often reduces the number of eye drops patients need afterward.
This makes trabeculectomy the preferred choice when the target pressure is very low, such as in advanced glaucoma with significant visual field loss. MIGS tends to suit earlier-stage disease where a moderate pressure reduction is sufficient. The choice comes down to how much pressure reduction you need, how much surgical risk you’re willing to accept, and what matters most to you in terms of recovery and long-term follow-up.
What to Expect on Surgery Day
Trabeculectomy is performed as an outpatient procedure, meaning you go home the same day. It can be done under local anesthesia or, less commonly, general anesthesia. Most surgeons use some form of local numbing, which may involve anesthetic drops on the eye surface combined with a small injection of numbing medication under the tissue where the surgery will take place. You’ll be awake but shouldn’t feel pain.
Before surgery, your care team may adjust certain medications. Blood thinners and antiplatelet drugs need to be discussed with the prescribing doctor, since they can increase bleeding risk. Your glaucoma drops may also be adjusted in the days leading up to the procedure, sometimes switching to anti-inflammatory drops to reduce the eye’s tendency to scar after surgery. On the day itself, antiseptic drops are applied to minimize infection risk.
During the operation, the surgeon typically applies an anti-scarring medication to the tissue around the surgical site. Scarring is the main reason trabeculectomies fail over time, so these medications are a critical part of the procedure. Two agents are commonly used, and the choice, concentration, and duration of application vary between surgeons and individual cases.
Recovery and Activity Restrictions
Recovery from trabeculectomy takes longer than most people expect. You’ll use medicated eye drops for several weeks afterward, and the operated eye needs consistent protection from injury. During the daytime, UV-blocking sunglasses are recommended whenever you’re outdoors, and you may be given a protective shield to wear at night.
For the first six weeks, you’ll need to avoid any activity that involves bending forward, including gardening, certain forms of prayer that require prostration, and picking up heavy objects. Strenuous exercise like running, jumping, and swimming is off limits until your eye doctor clears you. Physical contact sports require protective goggles even after you’ve healed. Sexual activity should also be paused until your surgeon gives the go-ahead. These restrictions exist because increased pressure in the head or a bump to the eye can disrupt the delicate healing process at the surgical site.
Your surgeon will see you frequently in the early weeks to monitor pressure and assess how the filtering bleb is forming. Sometimes stitches are selectively removed or loosened at follow-up visits to adjust the drainage rate. This ability to fine-tune results after surgery is one of trabeculectomy’s advantages.
Success Rates Over Time
Trabeculectomy is effective, but its success gradually declines as the body’s healing response narrows the drainage channel. In a long-term study, 82% of eyes had well-controlled pressure at one year. That dropped to 64% at three years and 52% at four years, with success defined as pressure at or below 21 mmHg using at most one eye drop. Without any drops at all, the numbers were lower: 63% at one year and 40% at four years.
When surgeons use anti-scarring medication during the procedure, long-term results improve. One study following patients for an average of five years found that the cumulative probability of success at eight years was about 66%. Certain types of glaucoma are harder to treat surgically. Pseudoexfoliation glaucoma, where flaky protein deposits clog the drainage system and promote scarring, carried roughly three times the risk of surgical failure. Neovascular glaucoma, caused by abnormal blood vessel growth inside the eye, was similarly challenging, with nearly triple the failure risk due to ongoing scarring and inflammation.
The Filtering Bleb
The bleb is the visible sign that the surgery is working. It’s a small, raised area on the surface of the eye where fluid collects before being absorbed. A healthy, functioning bleb has specific characteristics your doctor looks for during checkups: it should be slightly elevated, with a pale or translucent appearance, and internal imaging often reveals multiple small fluid-filled spaces within its walls. A bleb that becomes flat, thickened, or heavily scarred with a dense wall signals that drainage is slowing and the surgery may be failing.
The bleb sits under the upper eyelid in most cases, so it’s not visible to others. Because it’s a thin-walled pocket of tissue, it’s vulnerable to leaks and infection, which is why long-term eye protection and follow-up matter.
Possible Complications
Trabeculectomy carries real surgical risks, and the complication rate is not trivial. A 20-year population study found that about 20% of eyes experienced a complication within the first three months, and the cumulative chance of any complication over 20 years was 45%.
Early complications, those occurring in the first three months, are usually manageable. The most common is a small amount of bleeding inside the eye (hyphema), which typically resolves on its own within a few weeks. Low eye pressure (hypotony) and bleb leaks are also relatively frequent early on. Serious infections in this early window are rare.
Late complications are a bigger concern. Bleb leaks were the most common issue after three months, often requiring a return to surgery. Low pressure and fluid collection behind the eye were the next most frequent. The most serious late risks are infections: bleb infection (blebitis) had a 2% cumulative probability over 20 years, while a deeper infection inside the eye (endophthalmitis) reached about 5%. These infections can threaten vision and require urgent treatment, which is why lifelong monitoring is recommended after trabeculectomy. The risk of these serious infections grows as the years pass, likely because the bleb wall thins over time.
Why Trabeculectomy Still Matters
Despite newer, less invasive options, trabeculectomy remains essential for patients with advanced or poorly controlled glaucoma who need the lowest possible eye pressure. It delivers the most substantial pressure drop of any glaucoma surgery, and for people at high risk of going blind from the disease, that magnitude of reduction can be the difference between preserving useful vision and losing it. The trade-off is a longer recovery, more intensive follow-up, and a meaningful complication rate, all of which factor into the decision between trabeculectomy and less aggressive alternatives.